Annual Cash & Cash Equivalents
$14.33 M
+$3.56 M+33.00%
31 December 2023
Summary:
Longboard Pharmaceuticals annual cash & cash equivalents is currently $14.33 million, with the most recent change of +$3.56 million (+33.00%) on 31 December 2023. During the last 3 years, it has fallen by -$40.98 million (-74.09%). LBPH annual cash & cash equivalents is now -78.40% below its all-time high of $66.35 million, reached on 31 December 2021.LBPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$27.61 M
+$13.01 M+89.12%
30 September 2024
Summary:
Longboard Pharmaceuticals quarterly cash and cash equivalents is currently $27.61 million, with the most recent change of +$13.01 million (+89.12%) on 30 September 2024. Over the past year, it has increased by +$3.70 million (+15.47%). LBPH quarterly cash and cash equivalents is now -77.15% below its all-time high of $120.85 million, reached on 31 March 2021.LBPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.0% | +15.5% |
| 3 y3 years | -74.1% | -63.4% |
| 5 y5 years | - | - |
LBPH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.4% | +33.0% | -63.4% | +156.2% |
| 5 y | 5 years | -78.4% | +33.0% | -77.2% | +156.2% |
| alltime | all time | -78.4% | +33.0% | -77.2% | +156.2% |
Longboard Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.61 M(+89.1%) |
| June 2024 | - | $14.60 M(-73.2%) |
| Mar 2024 | - | $54.40 M(+279.6%) |
| Dec 2023 | $14.33 M(+33.0%) | $14.33 M(-40.1%) |
| Sept 2023 | - | $23.91 M(+22.6%) |
| June 2023 | - | $19.50 M(-22.4%) |
| Mar 2023 | - | $25.12 M(+133.1%) |
| Dec 2022 | $10.78 M | $10.78 M(-42.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $18.75 M(-32.4%) |
| June 2022 | - | $27.72 M(-20.9%) |
| Mar 2022 | - | $35.04 M(-47.2%) |
| Dec 2021 | $66.35 M(+19.9%) | $66.35 M(-12.1%) |
| Sept 2021 | - | $75.46 M(-16.9%) |
| June 2021 | - | $90.86 M(-24.8%) |
| Mar 2021 | - | $120.85 M(+118.5%) |
| Dec 2020 | $55.32 M | $55.32 M |
FAQ
- What is Longboard Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Longboard Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Longboard Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of LBPH is $14.33 M
What is the all time high annual cash & cash equivalents for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high annual cash & cash equivalents is $66.35 M
What is Longboard Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, LBPH annual cash & cash equivalents has changed by +$3.56 M (+33.00%)
What is Longboard Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LBPH is $27.61 M
What is the all time high quarterly cash and cash equivalents for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high quarterly cash and cash equivalents is $120.85 M
What is Longboard Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, LBPH quarterly cash and cash equivalents has changed by +$3.70 M (+15.47%)